Try our beta test site

MATRIX EG (Matuzumab Treatment With ECX in Esophago-Gastric Cancer)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck KGaA
ClinicalTrials.gov Identifier:
NCT00215644
First received: September 15, 2005
Last updated: November 4, 2016
Last verified: November 2016